CAD 0.58
(-8.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 285.32 Thousand CAD | 18.47% |
2022 | 240.84 Thousand CAD | 422.68% |
2021 | 46.07 Thousand CAD | -53.04% |
2020 | 98.12 Thousand CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 1.26 Million CAD | 343.82% |
2024 Q2 | 1.18 Million CAD | -6.21% |
2023 Q2 | 321.3 Thousand CAD | 39.31% |
2023 Q1 | 230.64 Thousand CAD | -4.24% |
2023 Q4 | 285.32 Thousand CAD | -43.31% |
2023 FY | 285.32 Thousand CAD | 18.47% |
2023 Q3 | 503.28 Thousand CAD | 56.64% |
2022 Q4 | 240.84 Thousand CAD | -3.96% |
2022 Q3 | 250.76 Thousand CAD | 1911.59% |
2022 Q2 | 12.46 Thousand CAD | -57.66% |
2022 Q1 | 29.44 Thousand CAD | -36.11% |
2022 FY | 240.84 Thousand CAD | 422.68% |
2021 Q1 | 83.44 Thousand CAD | 121.92% |
2021 FY | 46.07 Thousand CAD | -53.04% |
2021 Q3 | 53.18 Thousand CAD | -22.32% |
2021 Q2 | 68.46 Thousand CAD | -17.95% |
2021 Q4 | 46.07 Thousand CAD | -13.37% |
2020 Q4 | 37.6 Thousand CAD | 0.0% |
2020 FY | 98.12 Thousand CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
Asep Medical Holdings Inc | 20 Thousand CAD | -1326.63% |
BetterLife Pharma Inc. | 245.23 Thousand CAD | -16.348% |
BioVaxys Technology Corp. | - CAD | -Infinity% |
ChitogenX Inc. | 3.87 Million CAD | 92.637% |
Rapid Dose Therapeutics Corp. | 2.45 Million CAD | 88.371% |
Defence Therapeutics Inc. | 1.74 Million CAD | 83.662% |
Entheon Biomedical Corp. | - CAD | -Infinity% |
Glow Lifetech Corp. | 116.18 Thousand CAD | -145.581% |
Lexston Life Sciences Corp. | - CAD | -Infinity% |
Pharmala Biotech Holdings Inc. | 253.53 Thousand CAD | -12.538% |
Doseology Sciences Inc. | - CAD | -Infinity% |
MYND Life Sciences Inc. | 3 Million CAD | 90.489% |
Nova Mentis Life Science Corp. | - CAD | -Infinity% |
PharmaTher Holdings Ltd. | - CAD | -Infinity% |
PreveCeutical Medical Inc. | 3.83 Million CAD | 92.558% |
Telescope Innovations Corp. | - CAD | -Infinity% |